reference/10223242

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10223242

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1483
issn	1460-2083 0964-6906
issueIdentifier	16
pageRange	1469-1483
publicationName	Human Molecular Genetics
startingPage	1469
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5876bf8c7cb5154c8b08768c8fc56b81 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_dd0cf5e17b296c1ffde17a22a671e742 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8479fc75f87560fe7905f11a14ccd770
bibliographicCitation	Argyrofthalmidou M, Spathis AD, Maniati M, Poula A, Katsianou MA, Sotiriou E, Manousaki M, Perier C, Papapanagiotou I, Papadopoulou-Daifoti Z, Pitychoutis PM, Alexakos P, Vila M, Stefanis L, Vassilatis DK. Nurr1 repression mediates cardinal features of Parkinson's disease in α-synuclein transgenic mice. Hum Mol Genet. 2021 Jul 28;30(16):1469–83. PMID: 33902111; PMCID: PMC8330896.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86d38538e3c595b8d80f5bc4885fa96b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbb8eee80177b1962af08c4803e1c8c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6364b344a1d0a8ceb926b9682a8573bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aae5a24f30f1ea347bc5f775f2f6c5d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a6061d99cd2ba98856a56782d29ec11 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f03136440a3671ca3419341709f328ef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb359e2925271a3670faf63575a50028 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b032032e9b8d2057747aaafa3a86591b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec59684cd5034d59dde94aff1bfc2dda http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b319f57b711039b2764370a8bcdfeb42 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d67ba39973506bdc80b9685b3f00158a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be65da53ee93235017d8bf32e5282c2f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f83d1cd32dd16130f4ea43030652993 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8dcb70ee260729f45cf99eb2378b28db http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31648a17197066b3d45bb2d5b521aa3a
date	2021-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/33902111 https://pubmed.ncbi.nlm.nih.gov/PMC8330896 https://doi.org/10.1093/hmg/ddab118
isPartOf	https://portal.issn.org/resource/ISSN/0964-6906 https://portal.issn.org/resource/ISSN/1460-2083 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2407
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice
discusses	http://id.nlm.nih.gov/mesh/M0159750 http://id.nlm.nih.gov/mesh/M0534714 http://id.nlm.nih.gov/mesh/M0440448
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D051844Q000378 http://id.nlm.nih.gov/mesh/D051844Q000235 http://id.nlm.nih.gov/mesh/D010300Q000473 http://id.nlm.nih.gov/mesh/D057126Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D059290Q000378 http://id.nlm.nih.gov/mesh/D008822 http://id.nlm.nih.gov/mesh/D008636Q000378 http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_75a8e2e750809725a1336e798cd87256 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID2491 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aba283fcf2192afdf79c2b7da206ab70 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8805 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8636 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10435 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8781 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8253 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7133

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18227

Total number of triples: 62.